Myriad Genetics falls as anaylst cuts rating

January 4, 2013

Shares of Myriad Genetics Inc. fell Thursday after a JPMorgan analyst downgraded the stock, saying it will face headwinds while investors wait for a Supreme Court ruling that could have a major impact on the company. (Bloomberg Businessweek)